Daniel Char 's most recent trade in Western Asset High Income Opportunity Fund Inc was a trade of 10,000 Common Stock done at an average price of $4.0 . Disclosure was reported to the exchange on July 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Western Asset High Income ... | Peter Daniel Charles Mason | Director | Purchase of securities on an exchange or from another person at price $ 4.02 per share. | 14 Jul 2025 | 10,000 | 10,000 (0%) | 0% | 4.0 | 40,183 | Common Stock |
| LMP Capital and Income Fun... | Peter Daniel Charles Mason | Director | Purchase of securities on an exchange or from another person at price $ 15.59 per share. | 14 Jul 2025 | 2,580 | 2,580 (0%) | 0% | 15.6 | 40,221 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 13.13 per share. | 13 Jun 2025 | 381 | 149,698 (1%) | 0% | 13.1 | 5,003 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 258 | 49,209 (0%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | Charles Daniel Forman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 4,746 | 217,828 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 124,953 | 176,246 (1%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 13 Mar 2025 | 5,001 | 54,101 (0%) | 0% | 13.9 | 69,364 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 13 Mar 2025 | 1,864 | 51,293 (0%) | 0% | 14.3 | 26,748 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.94 per share. | 13 Mar 2025 | 944 | 53,157 (0%) | 0% | 13.9 | 13,159 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 261 | 48,951 (0%) | 0% | 0 | Common Stock | |
| Simmons First National Cor... | Charles Daniel Hobbs | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 10,644 | 10,644 | - | - | Restricted Stock Units | |
| Simmons First National Cor... | Charles Daniel Hobbs | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 3,794 | 7,588 | - | - | Restricted Stock Units | |
| Simmons First National Cor... | Charles Daniel Hobbs | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 3,794 | 6,341 (0%) | 0% | - | SFNC Common Stock | |
| Simmons First National Cor... | Charles Daniel Hobbs | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.97 per share. | 28 Feb 2025 | 1,528 | 4,813 (0%) | 0% | 22.0 | 33,570 | SFNC Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 10,602 | 48,690 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.83 per share. | 31 Jan 2025 | 8,155 | 38,088 (0%) | 0% | 88.8 | 724,409 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 149,317 | 149,317 (1%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 149,317 | 0 (0%) | 1% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 108,598 | 108,598 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 108,598 | 0 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 40,719 | 149,317 (1%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2024 | 40,719 | 59,102 (0%) | 0% | 0 | Common Stock | |
| Simmons First National Cor... | Hobbs Charles Daniel | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2024 | 4,200 | 16,800 | - | - | Restricted Stock Unit | |
| Simmons First National Cor... | Hobbs Daniel Charles | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.48 per share. | 04 Dec 2024 | 4,200 | 4,200 (0%) | 0% | 24.5 | 102,816 | SFNC Common Stock |
| Simmons First National Cor... | Charles Hobbs Daniel | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.48 per share. | 04 Dec 2024 | 1,653 | 2,547 (0%) | 0% | 24.5 | 40,465 | SFNC Common Stock |
| Cohen & Steers Inc. | P. Charles Daniel | Executive Vice President | Sale of securities on an exchange or to another person at price $ 103.73 per share. | 02 Dec 2024 | 6,768 | 46,140 (0%) | 0% | 103.7 | 702,045 | Common Stock |
| Cohen & Steers Inc. | Daniel Charles P. | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 203 | 46,243 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Charles P. Daniel | Executive Vice President | Sale of securities on an exchange or to another person at price $ 104.18 per share. | 02 Dec 2024 | 100 | 46,040 (0%) | 0% | 104.2 | 10,418 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 249 | 52,908 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 295 | 52,659 (0%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | Charles Daniel Forman | Director | Grant, award, or other acquisition of securities at price $ 47.20 per share. | 09 May 2024 | 4,237 | 213,082 (0%) | 0% | 47.2 | 199,986 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 1,859 | 99,821 (0%) | 0% | 36.6 | 68,058 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 942 | 101,680 (0%) | 0% | 36.6 | 34,487 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.61 per share. | 15 Mar 2024 | 608 | 102,622 (0%) | 0% | 36.6 | 22,259 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 300 | 52,364 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2024 | 45,087 | 103,230 (0%) | 0% | 0 | Common Stock | |
| Simmons First National Cor... | Daniel Hobbs Charles | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 11,382 | 11,382 | - | - | Restricted Stock Unit | |
| Medifast Inc | Chard Daniel R. | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 16,486 | 63,614 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | R. Chard Daniel | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.68 per share. | 14 Feb 2024 | 5,471 | 58,143 (0%) | 0% | 52.7 | 288,212 | Common Stock |
| Cohen & Steers Inc. | P. Daniel Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 13,111 | 52,064 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel Charles P. | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.42 per share. | 31 Jan 2024 | 6,524 | 38,953 (0%) | 0% | 72.4 | 472,468 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Nov 2023 | 355 | 45,477 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2023 | 319 | 45,122 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 375 | 44,803 (0%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | Charles Daniel Forman | Director | Grant, award, or other acquisition of securities at price $ 61.15 per share. | 11 May 2023 | 2,861 | 208,845 (0%) | 0% | 61.1 | 174,950 | Common Stock |
| Las Vegas Sands | Charles Daniel Forman | Director | Sale of securities on an exchange or to another person at price $ 63.17 per share. | 28 Apr 2023 | 15,000 | 205,984 (0%) | 0% | 63.2 | 947,550 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 317 | 44,428 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 34,076 | 48,194 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 16,807 | 47,128 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.99 per share. | 24 Feb 2023 | 15,643 | 32,551 (0%) | 0% | 110.0 | 1,720,574 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.46 per share. | 24 Feb 2023 | 1,358 | 31,193 (0%) | 0% | 104.5 | 141,857 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.75 per share. | 24 Feb 2023 | 872 | 30,321 (0%) | 0% | 102.8 | 89,598 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.31 per share. | 21 Feb 2023 | 1,815 | 14,118 (0%) | 0% | 115.3 | 209,288 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 15,669 | 44,111 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.74 per share. | 31 Jan 2023 | 4,337 | 28,442 (0%) | 0% | 71.7 | 311,136 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Nov 2022 | 236 | 32,779 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 201 | 32,543 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 208 | 32,342 (0%) | 0% | 0 | Common Stock | |
| Las Vegas Sands | Charles Daniel Forman | Director | Grant, award, or other acquisition of securities at price $ 30.14 per share. | 12 May 2022 | 5,806 | 220,984 (0%) | 0% | 30.1 | 174,993 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 183.28 per share. | 05 May 2022 | 431 | 108,598 (0%) | 0% | 183.3 | 78,995 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 192 | 32,134 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 8,509 | 21,139 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.52 per share. | 16 Mar 2022 | 878 | 20,261 (0%) | 0% | 180.5 | 158,497 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.06 per share. | 22 Feb 2022 | 1,804 | 13,912 (0%) | 0% | 177.1 | 319,416 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.06 per share. | 22 Feb 2022 | 1,282 | 12,630 (0%) | 0% | 177.1 | 226,991 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 3,375 | 16,886 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 3,375 | 107,214 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 953 | 15,933 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2022 | 953 | 108,167 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Purchase of securities on an exchange or from another person at price $ 186.47 per share. | 04 Feb 2022 | 690 | 103,839 (0%) | 0% | 186.5 | 128,667 | Common Stock |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 15,754 | 31,942 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.66 per share. | 31 Jan 2022 | 2,325 | 16,188 (0%) | 0% | 81.7 | 189,860 | Common Stock |
| Evelo Biosciences Inc | Daniel Char | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 319 | 18,513 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 90,610 | 15,716 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 90,610 | 90,610 (0%) | 0% | 0 | Common Stock | |
| Cohen & Steers Inc. | Daniel P. Charles | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 87 | 18,194 (0%) | 0% | 0 | Common Stock | |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 260.37 per share. | 17 Jun 2021 | 1,000 | 111,091 (0%) | 0% | 260.4 | 260,374 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 261.46 per share. | 17 Jun 2021 | 1,000 | 110,091 (0%) | 0% | 261.5 | 261,456 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 263.31 per share. | 17 Jun 2021 | 863 | 108,628 (0%) | 0% | 263.3 | 227,239 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 267.00 per share. | 17 Jun 2021 | 802 | 107,326 (0%) | 0% | 267.0 | 214,135 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 262.54 per share. | 17 Jun 2021 | 600 | 109,491 (0%) | 0% | 262.5 | 157,524 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 259.32 per share. | 17 Jun 2021 | 600 | 112,091 (0%) | 0% | 259.3 | 155,594 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 268.00 per share. | 17 Jun 2021 | 502 | 106,824 (0%) | 0% | 268.0 | 134,538 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 269.12 per share. | 17 Jun 2021 | 298 | 106,526 (0%) | 0% | 269.1 | 80,197 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 265.29 per share. | 17 Jun 2021 | 287 | 108,128 (0%) | 0% | 265.3 | 76,138 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 264.35 per share. | 17 Jun 2021 | 213 | 108,415 (0%) | 0% | 264.3 | 56,306 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 270.10 per share. | 17 Jun 2021 | 200 | 106,326 (0%) | 0% | 270.1 | 54,019 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 281.83 per share. | 15 Jun 2021 | 3,514 | 119,747 (1%) | 0% | 281.8 | 990,342 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 273.03 per share. | 15 Jun 2021 | 1,410 | 115,958 (0%) | 0% | 273.0 | 384,975 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 276.35 per share. | 15 Jun 2021 | 1,019 | 113,558 (0%) | 0% | 276.4 | 281,605 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 272.13 per share. | 15 Jun 2021 | 947 | 117,368 (0%) | 0% | 272.1 | 257,704 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 282.92 per share. | 15 Jun 2021 | 811 | 118,936 (1%) | 0% | 282.9 | 229,450 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 277.32 per share. | 15 Jun 2021 | 767 | 112,791 (0%) | 0% | 277.3 | 212,706 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 278.40 per share. | 15 Jun 2021 | 752 | 124,509 (1%) | 0% | 278.4 | 209,360 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 280.89 per share. | 15 Jun 2021 | 700 | 123,261 (1%) | 0% | 280.9 | 196,623 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 274.13 per share. | 15 Jun 2021 | 700 | 115,258 (0%) | 0% | 274.1 | 191,889 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 275.12 per share. | 15 Jun 2021 | 681 | 114,577 (0%) | 0% | 275.1 | 187,359 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 279.48 per share. | 15 Jun 2021 | 548 | 123,961 (1%) | 0% | 279.5 | 153,157 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 275.84 per share. | 15 Jun 2021 | 450 | 125,461 (1%) | 0% | 275.8 | 124,128 | Common Stock |
| Medifast Inc | Daniel R. Chard | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 284.03 per share. | 15 Jun 2021 | 421 | 118,515 (1%) | 0% | 284.0 | 119,578 | Common Stock |